Assisting Pulmonary Hypertension Patients and Families With Treatment Decisions

2010 ◽  
Vol 8 (4) ◽  
pp. 239-243
Author(s):  
Karen Frutiger ◽  
Martha Kingman ◽  
Abby Poms ◽  
Glenna Traiger
Keyword(s):  
North Carolina ◽  
Pulmonary Hypertension ◽  
Los Angeles ◽  
Medical Center ◽  
Pulmonary Vascular Disease ◽  
University Of Texas ◽  
Program Manager ◽  
Nurse Coordinator ◽  
Duke University ◽  
Pulmonary Arterial

To complement this issue's theme, “Living With Pulmonary Hypertension,” a discussion on assisting patients with therapy decisions was led by guest editor Glenna Traiger, RN, MSN, Pulmonary Hypertension CNS, University of California, Los Angeles. The panelists included Karen Frutiger, RN, Clinical Nurse Coordinator, University of Rochester Pulmonary Arterial Hypertension Program, Rochester, NY; Martha Kingman, Nurse Practitioner, University of Texas Southwestern Medical Center, Dallas; and Abby Poms, RRT, Duke University Pulmonary Vascular Disease Program Manager, Duke University Medical Center, Durham, North Carolina.

scholarly journals Bench to Bedside: Principles and Practice of Epoprostenol Therapy, from Maximizing Benefit to Minimizing Side Effects

2002 ◽  
Vol 1 (3) ◽  
pp. 22-25
Author(s):  
Ivan Robbins ◽  
David Langleben ◽  
Michael McGoon ◽  
Abby Krichman
Keyword(s):  
North Carolina ◽  
Pulmonary Hypertension ◽  
Side Effects ◽  
Mayo Clinic ◽  
Medical Center ◽  
Pulmonary Vascular Disease ◽  
Jewish General Hospital ◽  
Mcgill University ◽  
Duke University ◽  
Vanderbilt University

Ivan Robbins, MD, Director, Pulmonary Hypertension Center, Vanderbilt University, Nashville, Tennessee, conducted this discussion. The panel included David Langleben, MD, Director, Center for Pulmonary Vascular Disease, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; Michael McGoon, MD, Consultant in Cardiology, Mayo Clinic, Rochester, Minnesota; and Abby Krichman, RRT, Pulmonary Hypertension Coordinator, Duke University Medical Center, Durham, North Carolina.

Protocols in Heart and Lung Transplantation: An Essential Guide to Preoperative Assessment and Timing to Improve Outcomes

2004 ◽  
Vol 3 (1) ◽  
pp. 20-25
Author(s):  
Victor Tapson ◽  
Robert Frantz ◽  
John Conte
Keyword(s):  
North Carolina ◽  
Pulmonary Hypertension ◽  
Critical Care ◽  
Lung Transplantation ◽  
Medical Center ◽  
Preoperative Assessment ◽  
Assistant Professor ◽  
Associate Professor ◽  
Johns Hopkins University ◽  
Duke University

This discussion was moderated by Victor Tapson, MD, Editor-in-Chief of Advances in Pulmonary Hypertension and Associate Professor, Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina. The participants included Robert Frantz, MD, Assistant Professor of Medicine, Cardiovascular Division, Mayo Clinic, Rochester, Minnesota; and John Conte, MD, Associate Professor of Surgery and Director of Heart and Lung Transplantation, Johns Hopkins University, Baltimore, MD.

Pulmonary Hypertension Roundtable: COPD, IPF, and Pulmonary Hypertension: A Clinician's Dilemma

2013 ◽  
Vol 12 (3) ◽  
pp. 145-151
Keyword(s):  
Pulmonary Hypertension ◽  
Rhode Island ◽  
Medical Center ◽  
Puget Sound ◽  
Health Science ◽  
Pulmonary Vascular Disease ◽  
University Hospitals ◽  
Science Center ◽  
University Of Texas ◽  
Transplant Program

On October 9, 2013, a group of experts met by telephone to discuss PH in the setting of COPD and IPF. The group consisting of guest editor of this issue Jeffrey Edelman, MD, Head, Lung Transplant Program VA Puget Sound Health System, University of Washington; Deborah J. Levine, MD, Director, Pulmonary Hypertension Center, University of Texas Health Science Center at San Antonio; James Klinger, MD, Director, Rhode Island Hospital Pulmonary Hypertension Center; and Robert Schilz, DO, PhD, Director of Pulmonary Vascular Disease and Lung Transplantation, University Hospitals, Case Medical Center; provided perspective and insight into how clinicians can approach these patients most effectively.

NEWS AND ANNOUNCEMENTS

PEDIATRICS ◽  
1972 ◽  
Vol 50 (1) ◽  
pp. 173-174
Keyword(s):  
North Carolina ◽  
American Academy ◽  
Continuing Education ◽  
Medical Center ◽  
Perinatal Medicine ◽  
University Of Texas ◽  
American Academy Of Pediatrics ◽  
Texas Medical School ◽  
Duke University ◽  
The University

Newborn Symposium: The Seventeenth Annual Angus M. McBryde Newborn Symposium will be held September 14 and 15, 1972, at Duke UniversityMedical Center, Durham, North Carolina. For information write to George W. Brumley, M.D., Division of Perinatal Medicine, Box 2911, Duke University Medical Center, Durham, North Carolina 27710. The American Academy of Pediatrics Continuing Education Course: The American Academy of Pediatrics will co-sponsor a continuing education course on General Pediatrics with the University of Texas Medical School, San Antonio, Texas, September 14, 15, and 16, 1972, under the chairmanship of Stanley E. Crawford, M.D.

scholarly journals Pulmonary Hypertension Roundtable: New Invasive Technologies in Pulmonary Hypertension

2020 ◽  
Vol 19 (1) ◽  
pp. 25-32
Keyword(s):  
Pulmonary Hypertension ◽  
Los Angeles ◽  
University Hospital ◽  
Pulmonary Vascular Disease ◽  
State University ◽  
Cardiovascular Medicine ◽  
School Of Medicine ◽  
Duke University ◽  
The Ohio State University ◽  
The University

This spring, Guest Editor Richard A. Krasuski, MD, Professor of Medicine at Duke University School of Medicine in Durham, North Carolina, convened a group of experts to discuss the present and future of invasive technologies in the diagnosis and treatment of pulmonary hypertension. The guests included Jamil A. Aboulhosn, MD, Professor of Medicine at the University of California Los Angeles David Geffen School of Medicine in Los Angeles, California; Raymond Benza, MD, Director of the Division of Cardiovascular Medicine and Professor of Medicine at The Ohio State University College of Medicine in Columbus, Ohio; and J. Eduardo Rame, MD, FACC, Louis R. Dinon MD Professor of Cardiovascular Medicine and Physiology and Chief for Advanced Cardiac and Pulmonary Vascular Disease at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania.

Pulmonary Hypertension Roundtable: Recapping 5 Years, Exploring Emerging Approaches

2006 ◽  
Vol 5 (4) ◽  
pp. 32-39 ◽  
Author(s):  
Vallerie V. McLaughlin ◽  
Richard N. Channick ◽  
Ivan M. Robbins ◽  
Victor F. Tapson
Keyword(s):  
North Carolina ◽  
Pulmonary Hypertension ◽  
Critical Care ◽  
San Diego ◽  
Medical Center ◽  
Associate Professor ◽  
University Of Michigan ◽  
Ann Arbor ◽  
Duke University ◽  
Vanderbilt University

This discussion was moderated by Vallerie V. McLaughlin, MD, Associate Professor of Medicine and Director, Pulmonary Hypertension Program, University of Michigan Health System, Ann Arbor, Michigan. Panel members included Richard N. Channick, MD, Associate Professor of Medicine, Pulmonary and Critical Care Division, University of California, San Diego Medical Center, San Diego, California; Ivan M. Robbins, MD, Director of the Pulmonary Hypertension Center, Vanderbilt University, Nashville, Tennessee; and Victor F. Tapson, MD, Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina.

scholarly journals Pulmonary Hypertension Roundtable: CTEPH Experiences and Expertise

2014 ◽  
Vol 12 (4) ◽  
pp. 199-205
Keyword(s):  
Pulmonary Hypertension ◽  
Clinical Medicine ◽  
Massachusetts General Hospital ◽  
Medical Center ◽  
Chronic Thromboembolic Pulmonary Hypertension ◽  
Vascular Diseases ◽  
Pulmonary Vascular Disease ◽  
Thromboembolic Pulmonary Hypertension ◽  
Duke University ◽  
The University

On February 6, 2014, a group of physicians with expertise related to Chronic Thromboembolic Pulmonary Hypertension (CTEPH) met on a conference call to discuss topics related to the disease. The call was hosted by the guest editor of this issue, Richard Channick, MD, the Director of the Pulmonary Hypertension and Thromboendarterectomy Program at Massachusetts General Hospital. Dr. Channick was joined by Victor Tapson, MD, Professor of Medicine in the Division of Pulmonary and Critical Care Medicine at Duke University Medical Center and Director of the Duke Pulmonary Vascular Disease Center; Joanna Pepke-Zaba, PhD, FRCP, Lead Physician and Director, National Pulmonary Vascular Diseases Unit at the Papworth Hospital, University of Cambridge, UK; Vallerie McLaughlin, MD, Professor of Internal Medicine at the University of Michigan; and Bill Auger, MD, Professor of Clinical Medicine and Director of Academic Affairs of the PTE Program at University of California-San Diego.

scholarly journals Heart and lung transplantation in pulmonary arterial hypertension related to congenital heart disease: an unusual indication

2020 ◽  
Vol 4 (S1) ◽  
Author(s):  
Rosaria Barracano ◽  
Heba Nashat ◽  
Andrew Constantine ◽  
Konstantinos Dimopoulos
Keyword(s):  
Pulmonary Hypertension ◽  
Pulmonary Arterial Hypertension ◽  
Arterial Hypertension ◽  
Lung Transplantation ◽  
Atrial Septal Defect ◽  
Septal Defect ◽  
Pulmonary Vascular Disease ◽  
Eisenmenger Syndrome ◽  
Pulmonary Arterial ◽  
Recurrent Haemoptysis

Abstract Background Eisenmenger syndrome is a multisystem disorder, characterised by a significant cardiac defect, severe pulmonary hypertension and long-standing cyanosis. Despite the availability of pulmonary hypertension therapies and improved supportive care in specialist centres, Eisenmenger patients are still faced with significant morbidity and mortality. Case presentation We describe the case of a 44-year-old woman with Eisenmenger syndrome secondary to a large secundum atrial septal defect. Her pulmonary vascular disease was treated with pulmonary vasodilators, but she experienced a progressive decline in exercise tolerance, increasing atrial arrhythmias, resulting in referral for transplantation. Her condition was complicated by significant recurrent haemoptysis in the context of extremely dilated pulmonary arteries and in-situ thrombosis, which prompted successful heart and lung transplantation. She made a slow recovery but remains well 3 years post-transplant. Conclusions Patients with Eisenmenger syndrome secondary to a pre-tricuspid lesion, such as an atrial septal defect have a natural history that differs to patients with post-tricuspid shunts; the disease tends to present later in life but is more aggressive, prompting early and aggressive medical intervention with pulmonary arterial hypertension therapies. This case illustrates that severe recurrent haemoptysis can be an indication for expediting transplantation in Eisenmenger syndrome patients.

Techniques' Comparison and Report of the North Carolina Experience

PEDIATRICS ◽  
1989 ◽  
Vol 83 (5) ◽  
pp. 843-848
Author(s):  
Thomas R. Kinney ◽  
Martha Sawtschenko ◽  
Mary Whorton ◽  
Jean Shearin ◽  
Christy Stine ◽  
...  
Keyword(s):  
North Carolina ◽  
Filter Paper ◽  
Screening Program ◽  
Medical Center ◽  
Sample Collection ◽  
Capillary Tubes ◽  
Blood Samples ◽  
Screening Programs ◽  
The North ◽  
Duke University

Controversy still exists as to the best laboratory method to use to screen newborns for sickle cell disease and other hemoglobinopathies. The proposed methods include hemoglobin electrophoresis, column chromatography, isoelectric focusing, and high performance liquid chromatography. There is also debate concerning the preferred method of sample collection. The proposed methods of sample collection include cord blood or blood obtained from the infant collected in a tube with anticoagulant or on filter paper. We compared hemoglobin electrophoresis patterns from infant blood samples collected in heparinized capillary tubes and on filter paper. This comparison was performed because hemoglobin electrophoresis of dried blood samples collected on filter paper has been advocated as a practical, reliable, and inexpensive method for mass screening programs, although the limitations of this technique have not been explored fully. We also summarize data from the North Carolina Newborn Hemoglobinopathy Screening Program, which relates to the advantages and limitations of hemoglobin electrophoresis from filter paper blood specimens. MATERIALS AND METHODS Specimens Four sets of specimens were used for this study: (1) specimens collected at Duke University Medical Center to compare hemoglobin electrophoresis patterns of hemolysates from filter paper and heparinized capillary tubes, (2) specimens collected by the North Carolina program for hemoglobinopathy screening, (3) specimens routinely collected at Duke University in heparinized capillary tubes for newborn hemoglobinopathy screening, and (4) samples for retesting to examine the error rate of the state program and to confirm screening results compatible with a hemoglobinopathy. Samples for Direct Comparison Between Filter Paper and Heparinized Specimens

scholarly journals Pulmonary Hypertension Roundtable: The Role of Exercise in Clinical Practice and Clinical Trials

2019 ◽  
Vol 18 (2) ◽  
pp. 63-67
Keyword(s):  
Clinical Trials ◽  
Pulmonary Hypertension ◽  
Heart Disease ◽  
Clinical Practice ◽  
Los Angeles ◽  
Guest Editor ◽  
Harvard Medical School ◽  
Medical Center ◽  
Professor Emeritus

On May 20, 2019, Guest Editor Ronald Oudiz, MD, Director of the Pulmonary Hypertension Program at Harbor-UCLA Medical Center in Los Angeles, California, led a discussion with Aaron Waxman, MD, PhD, Director of the Center for Pulmonary Heart Disease at Brigham and Women's Hospital and Harvard Medical School in Boston, Massachusetts, and Robert Naeije, MD, Professor Emeritus at the Free University of Brussels, Belgium.

Sign in / Sign up

Export Citation Format

Share Document